Eli Lilly under pressure: Can they solve GLP-1 supply squeeze?

Specific doses of Eli Lilly’s GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and frustrated patients are urging the pharma giant to act – fast.

Related Keywords

Vietnam ,Republic Of ,Canada ,India ,Eli Lilly ,Novo Nordisk Wegovy ,Nicolas Schmitz ,Novo Nordisk ,Dave Knapp ,Lars Fruergaard ,Lilly Mounjaro ,Vikram Shanbhag ,David Ricks ,Bloomberg ,Novo Holdings ,Bio Pharma ,Big Night ,Mounjaro User Dave Knapp ,Markets Amp Regulations ,Biopharma Culture ,Pipelines ,Emerging Markets ,Illy ,Obesity ,Diabetes ,